Richard Fox

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi et al. · Journal of Clinical Oncology · 2014 · 2.8K citations · Full text

Medicine, Oncology, Clinical Epidemiology +16

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial

Tim Meyer, Richard Fox, Yuk Ting et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 497 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer

Latha Kadalayil, Roberto Benini, Lalit Pallan et al. · Annals of Oncology · 2013 · 378 citations · Full text

Medicine, Oncology, Surgery +17

Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.

John Primrose, Richard Fox, Daniel H. Palmer et al. · Journal of Clinical Oncology · 2017 · 189 citations

Medicine, Oncology, Surgery +15